相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation Between Clinical Outcome and Growth Factor Pathway Expression in Osteogenic Sarcoma
Ayesha Abdeen et al.
CANCER (2009)
Novel agents for the treatment of adenocarcinoma of the pancreas
R. Pamela Mackenzie et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond
Paul M. Harari et al.
SEMINARS IN RADIATION ONCOLOGY (2009)
Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib
Tiziana Servidei et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells
Niels Eckstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB Ligands and remain dependent on the ErbB receptor network
Christoph A. Ritter et al.
CLINICAL CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance
F. Wang et al.
ONCOGENE (2007)
Breast cancer: The upgraded role of HER-3 and HER-4
Michalis V. Karamouzis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S. Zhou et al.
CANCER CELL (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
ErbB-receptors expression and survival in breast carcinoma: A 15-year follow-up study
S Bianchi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells
DB Ramnarain et al.
CANCER RESEARCH (2006)
Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers
N Ishikawa et al.
CANCER RESEARCH (2005)
TGFα expression impairs trastuzumab-induced HER2 downregulation
G Valabrega et al.
ONCOGENE (2005)
Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity
BS Kochupurakkal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Neuregulins: functions, forms, and signaling strategies
DL Falls
EXPERIMENTAL CELL RESEARCH (2003)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer
D Raben et al.
SEMINARS IN ONCOLOGY (2002)
Relevance of biologic markers in colorectal carcinoma - A comparative study of a broad panel
C Barozzi et al.
CANCER (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Gemcitabine: Progress in the treatment of pancreatic cancer
V Heinemann
ONCOLOGY (2001)
分享论文
